Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC 10135-0748-01
Published September 13, 2023 · Recall initiated: August 25, 2023
Summary
FDA records drug Class II recall D-1170-2023, published September 13, 2023 and initiated August 25, 2023. Recalling firm: Marlex Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 94/100 count bottles; Lot: E3811, expiration date 02/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Marlex Pharmaceuticals, Inc.
- Distributor
- Nationwide in the US.
- Lot
- E3811, expiration date 02/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADigoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: MarlexSeptember 13, 2023
- FDACooperstown Cheese Company 1. Jersey Girl 2. Toma Celena 3. Abbie 4. SK 5. Jersey Girl with garlic/rosemarySeptember 13, 2023
- FDACapsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDCSeptember 13, 2023
- FDANestle Toll House, Chocolate Chip Cookie Dough, 16.5 oz. Cookie dough in bar form packaged in paperboard traySeptember 13, 2023
- FDASodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus Mild CleaningSeptember 13, 2023
- FDAAcetaminophen Tablets, 500 mg, 100-count bottles, Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DEOctober 9, 2013
Questions about this recall
Was Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC 10135-0748-01 recalled?
Yes. FDA published recall D-1170-2023 on September 13, 2023. Reported hazard: Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter